Scoopfeeds — Intelligent news, curated.
Guggenheim initiates Bicara Therapeutics stock with buy rating
business

Guggenheim initiates Bicara Therapeutics stock with buy rating

Investing.com · May 11, 2026, 4:47 AM · Also reported by 2 other sources

Guggenheim initiates Bicara Therapeutics stock with buy rating

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop